Gene · 7706
Papers2,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Duck TRIM35 Promotes Tembusu Virus Replication by Interfering with RIG-I-Mediated Antiviral Signaling in Duck Embryo Fibroblasts. | Microbiol Spectr | 2022 | 36445078 | PubTator, text mining | PubMed |
| Transcriptomic response to ISAV infection in the gills, head kidney and spleen of resistant and susceptible Atlantic salmon. | BMC Genomics | 2022 | 36443659 | PubTator, text mining | PubMed |
| The lncRNAs involved in regulating the RIG-I signaling pathway. | Front Cell Infect Microbiol | 2022 | 36439216 | PubTator, text mining | PubMed |
| The polymerase δ-interacting protein family and their emerging roles in diseases. | Front Med (Lausanne) | 2022 | 36425112 | PubTator, text mining | PubMed |
| Modulation of HERV Expression by Four Different Encephalitic Arboviruses during Infection of Human Primary Astrocytes. | Viruses | 2022 | 36423114 | PubTator, text mining | PubMed |
| Dynamic quality control machinery that operates across compartmental borders mediates the degradation of mammalian nuclear membrane proteins. | Cell Rep | 2022 | 36417855 | PubTator, text mining | PubMed |
| ISG15 driven cellular responses to virus infection. | Biochem Soc Trans | 2022 | 36416643 | PubTator, text mining | PubMed |
| Emerging potential of ubiquitin-specific proteases and ubiquitin-specific proteases inhibitors in breast cancer treatment. | World J Clin Cases | 2022 | 36405275 | PubTator, text mining | PubMed |
| Structural and functional asymmetry of RING trimerization controls priming and extension events in TRIM5α autoubiquitylation. | Nat Commun | 2022 | 36402777 | PubTator, text mining | PubMed |
| Progressive hemifacial atrophy in a Chinese patient: A case report. | Medicine (Baltimore) | 2022 | 36401472 | PubTator, text mining | PubMed |
| GTF3A mutations predispose to herpes simplex encephalitis by disrupting biogenesis of the host-derived RIG-I ligand RNA5SP141. | Sci Immunol | 2022 | 36399538 | PubTator, text mining | PubMed |
| Defining the characteristics of interferon-alpha-stimulated human genes: insight from expression data and machine learning. | Gigascience | 2022 | 36399061 | PubTator, text mining | PubMed |
| The equilibrium of tumor suppression: DUBs as active regulators of PTEN. | Exp Mol Med | 2022 | 36385557 | PubTator, text mining | PubMed |
| Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics. | 3 Biotech | 2022 | 36382241 | PubTator, text mining | PubMed |
| Insight into the physiological and pathological roles of USP44, a potential tumor target (Review). | Oncol Lett | 2022 | 36380875 | PubTator, text mining | PubMed |
| The E3 ligase subunit FBXO45 binds the interferon-λ receptor and promotes its degradation during influenza virus infection. | J Biol Chem | 2022 | 36379255 | PubTator, text mining | PubMed |
| Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer. | Mol Cancer | 2022 | 36376892 | PubTator, text mining | PubMed |
| Atypical E3 ligase ZFP91 promotes small-molecule-induced E2F2 transcription factor degradation for cancer therapy. | EBioMedicine | 2022 | 36375317 | PubTator, text mining | PubMed |
| Buffy Coat Transcriptomic Analysis Reveals Alterations in Host Cell Protein Synthesis and Cell Cycle in Severe COVID-19 Patients. | Int J Mol Sci | 2022 | 36362378 | PubTator, text mining | PubMed |
| Reprograming of Gene Expression of Key Inflammatory Signaling Pathways in Human Peripheral Blood Mononuclear Cells by Soybean Lectin and Resveratrol. | Int J Mol Sci | 2022 | 36361735 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7706/papers?page=33